Prof Benjamin Thierry is the University of South Australia Professor of Bioengineering and a Research Leader at the Future Industries Institute. He is a NHMRC Investigator Fellow and the Head of the South Australian Node of the ARC Centre of Excellence in Convergent Bio and Nano Science and Technology (CBNS). He received his PhD in Biomedical Engineering from McGill University in 2004 and has since received prestigious awards, including two Career Development Fellowships. He was awraded in 2020 a NHMRC Investigator Fellowships (Addressing Healthcare Disparities in Remote and Low Resource Settings with Solid-State Biodiagnostic Devices).
Prof Thierry leads the translational Bioengineering group which aims to develop and... Read more
About me
Prof Benjamin Thierry is the University of South Australia Professor of Bioengineering and a Research Leader at the Future Industries Institute. He is a NHMRC Investigator Fellow and the Head of the South Australian Node of the ARC Centre of Excellence in Convergent Bio and Nano Science and Technology (CBNS). He received his PhD in Biomedical Engineering from McGill University in 2004 and has since received prestigious awards, including two Career Development Fellowships. He was awraded in 2020 a NHMRC Investigator Fellowships (Addressing Healthcare Disparities in Remote and Low Resource Settings with Solid-State Biodiagnostic Devices).
Prof Thierry leads the translational Bioengineering group which aims to develop and implement novel biodiagnostic and prognostic technologies and is currently involved in several clinical translation/commercialization activities. A significant outcome of his research has been the development of a patented cancer staging diagnostic technology that has received substantial commercial interest and investment through a spin-off company, Ferronova Pty Ltd. Ferronova has raised over $3.5 million in 2020 to fund several on-going clinical trials in Australia and the US. Another significant research focus is the development of biodiagnostic technologies aimed at improving prenatal care, especially in rural and low-ressource settings. In close collaboration with industry partners and clinicians, he is leading a comprehensive research program aimed at enabling better detection and treatment of pregnancy complications such as preeclampsia and pre-term birth. He co-founded SanguisDx in 2020 to accelerate the development of his solid-state diagnostic platform. He has also developed and patented a technology aimed at enabling comprehensive non-invasive prenatal genetic testing, which is currently being developed through a NHMRC Development Grant.
With the support of the ARC Centre of Excellence in Convergent Bio and Nano Science, Prof Thierry leads a research program oaimed at the development of next-generation in vitro organ and disease models, including models based on "organs-on-chips" concept and 3D Bioprinting. A specific focus is on patients derived tumour-on-chip models that recapitulate the tumour microenvironment. These models are being used to assist in the development of better cancer therapeutics, including based on ionizing radiation and immunotherapy.
About me
Doctor of Philosophy McGill University
Master of Applied Science Ecole Polytechnique de Montreal
Bachelor of Engineering Institute National Polytechnique de Grenoble
The Bioengineering group aims at bridging the gap between engineering and medicine, with specific focus on oncology and prenatal diagnostics. To this end, we are developing a range of technologies aimed at providing either basic insights about biological processes or designed to address significant biomedical challenges. More info can be find on our web site: www.bionanoengineering.com.
Current research areas:
Research
Excludes commercial-in-confidence projects.
CRC P: Nanoparticle manufacturing and its application in brain cancer radiotherapy, CRC-P, 09/01/2023 - 09/06/2026
Preclinical validation of a new molecular magnetic resonance imaging of glioblastoma towards improved image-guided treatment, Tour de Cure Ltd, 01/07/2023 - 01/07/2024
Point of Care Testing for Preeclampsia Towards Improving Antenatal Care in Rural Australia, The Hospital Research Foundation, 01/02/2022 - 31/01/2024
Development of Superior Sentinel Lymph Node Mapping Procedures using Magnetic Tracers, NHMRC - Development Grant, 01/01/2019 - 30/09/2022
FAPi-MRI towards Better target delineation of high-grade Gliomas, Neurosurgical Research Foundation, 30/08/2021 - 31/08/2022
AAS - Portable Healthcare: High-Value Micro/Nano-Scale Structures and Coating for Mass Production of Biomedical Devices, Australian Academy of Science, 01/11/2017 - 28/02/2022
Detection and viability of waterborne pathogens using a gut-on-chip, ARC - Linkage Project, 12/12/2018 - 11/12/2021
Preoperative Imaging of Metastatic Deposits in Regional Lymph Nodes: Preclinical Validation of a New Staging Modality for Head and Neck Cancer, NHMRC - Project Grant, 01/01/2019 - 31/07/2021
ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, ARC - Centre of Excellence, 01/04/2014 - 29/06/2021
Nanoscale silicon field-effect transistor diagnostic technology, ARC - Discovery Projects, 27/03/2017 - 31/12/2020
Development of Superior Sentinel Lymph Node Staging Procedures in Head and Neck Cancer Using Magnetic Tracers, Garnett Passe & Rodney Williams Memorial Foundation-Conjoint Grant, 01/06/2018 - 31/05/2020
Targeting particulate carriers to epithelial M cells, ARC - Linkage Project, 15/12/2015 - 30/09/2019
Advanced technologies for improved molecular diagnostic and prognostic of gastrointestinal cancers, NHMRC - Career Development Fellowship, 01/01/2015 - 31/12/2018
Nanomedicines Immunotargeting: Hitting the Target or Lost In Translation?, NHMRC - Project Grant, 01/01/2013 - 31/12/2016
NHMRC Equip 2015 - Stage-top incubator for live-cell imaging with the Zeiss LSM 710 super-high resolution microscope, NHMRC - Equipment Only Grants, 01/01/2016 - 31/12/2016
A novel nitric oxide-based treatment for recalcitrant Staphylococcus aureus-associated chronic rhinosinusitis (admin by Uni of Adelaide), NHMRC - Project Grant, 01/01/2013 - 30/06/2016
Research
Research outputs for the last seven years are shown below. Some long-standing staff members may have older outputs included. To see earlier years visit ORCID, ResearcherID or Scopus
Open access indicates that an output is open access.
Year | Output |
---|---|
2019 |
76
66
2
|
2019 |
17
15
58
|
2019 |
Open access
19
16
2
|
2019 |
Open access
15
11
1
|
2016 |
Open access
50
46
54
|
Year | Output |
---|---|
2012 |
1
|
2011 |
|
2009 |
3
|
Year | Output |
---|---|
2023 |
Open access
|
2023 |
Open access
2
|
2023 |
Open access
1
1
|
2023 |
|
2023 |
Open access
3
3
|
2022 |
Open access
15
|
2022 |
Open access
2
1
1
|
2022 |
3
3
|
2022 |
1
6
|
2022 |
Open access
3
3
2
|
2022 |
Open access
7
|
2022 |
5
3
1
|
2022 |
6
1
4
|
2022 |
Open access
11
6
5
|
2022 |
Open access
|
2022 |
2
1
1
|
2022 |
Open access
2
1
|
2022 |
2
|
2022 |
Open access
6
6
1
|
2022 |
Open access
1
1
1
|
2022 |
Open access
1
|
2022 |
1
1
1
|
2022 |
14
8
10
|
2021 |
Open access
7
6
|
2021 |
Open access
13
11
|
2021 |
Open access
6
4
|
2021 |
|
2021 |
Open access
5
5
7
|
2021 |
Open access
13
9
4
|
2021 |
Open access
7
6
6
|
2021 |
Open access
7
4
|
2020 |
7
7
1
|
2020 |
Open access
3
2
|
2020 |
Open access
17
11
2
|
2020 |
Open access
13
12
2
|
2020 |
16
16
3
|
2020 |
Open access
18
14
4
|
2020 |
Open access
60
51
1
|
2020 |
Open access
87
79
4
|
2019 |
76
66
2
|
2019 |
17
15
58
|
2019 |
Open access
4
3
4
|
2019 |
24
21
|
2019 |
Open access
19
16
2
|
2019 |
Open access
6
6
4
|
2019 |
Open access
15
11
1
|
2019 |
Open access
41
40
3
|
2019 |
14
11
1
|
2019 |
Open access
11
|
2019 |
Open access
8
7
3
|
2019 |
9
8
7
|
2018 |
Open access
15
15
1
|
2018 |
Open access
2
3
|
2018 |
Open access
5
3
|
2018 |
5
3
1
|
2018 |
Open access
77
60
14
|
2018 |
Open access
30
28
63
|
2017 |
Open access
22
22
|
2017 |
9
8
1
|
2017 |
25
21
|
2017 |
69
67
|
2017 |
Open access
1
1
|
2017 |
38
34
|
2016 |
Open access
50
46
54
|
2016 |
30
28
1
|
2016 |
2
|
2016 |
Open access
19
19
3
|
2016 |
8
5
|
2016 |
Open access
38
36
2
|
2016 |
25
25
4
|
2016 |
25
22
|
2015 |
Open access
23
22
|
2015 |
Open access
46
42
3
|
2015 |
Open access
61
58
14
|
2015 |
Open access
110
98
|
2015 |
35
31
9
|
2015 |
Open access
23
23
1
|
2015 |
Open access
45
42
|
2015 |
24
22
|
2015 |
14
12
|
2015 |
Open access
9
10
3
|
2014 |
48
47
1
|
2014 |
21
20
|
2014 |
Open access
13
11
|
2014 |
26
22
1
|
2014 |
27
26
|
2014 |
Open access
35
31
1
|
2014 |
4
6
|
2014 |
41
35
3
|
2014 |
30
28
|
2014 |
35
38
6
|
2014 |
7
8
|
2014 |
46
41
|
2014 |
Open access
14
15
|
2014 |
4
3
|
2014 |
116
112
4
|
2014 |
Open access
73
68
5
|
2014 |
29
30
|
2014 |
45
41
1
|
2013 |
Open access
13
12
|
2013 |
36
29
|
2012 |
11
8
|
2012 |
48
43
|
2012 |
42
39
|
2012 |
35
32
|
2011 |
13
11
|
2011 |
34
32
|
2010 |
77
70
|
2010 |
172
156
|
2010 |
Open access
31
29
|
2010 |
50
46
|
2010 |
52
48
|
2009 |
32
28
|
2009 |
73
|
2009 |
32
27
|
2009 |
27
29
|
2009 |
97
94
|
2008 |
|
2008 |
4
2
|
2008 |
83
78
|
2008 |
85
82
|
2008 |
32
30
|
Year | Output |
---|---|
2015 |
Open access
|
2015 |
1
|
2015 |
2
2
|
2013 |
3
3
|
Research
The Bioengineering group aims at bridging the gap between engineering and medicine, with specific focus on oncology and prenatal diagnostics. To this end, we are developing a range of technologies aimed at providing either basic insights about biological processes or designed to address significant biomedical challenges. More info can be find on our web site: www.bionanoengineering.com.
Current research areas:
Research
Details | Registry | Status |
---|---|---|
Thierry, Benjamin; Nelson, Melanie Ruth Maria; Milanova, Valentina; Dmochowska, Nicole; Pham, Thi Hanh Nguyen; Hawkett, Brian Stanley |
World | Filed |
Sensing of molecules by electrochemical detection of nanoparticles Wolfrum, Bernhard; Adly Hassan, Nouran Yehia; Rinklin, Philipp; Grob, Leroy; Hayden, Oliver; Weiss, Lennart; Tran, Phu Duy; Thierry, Benjamin |
World | Granted |
Sensor for detection of magnetic particles Cousins, Aidan Mark Francis; Thierry, Benjamin; Wedding, A Bruce; Forero Morales, Daniel |
WO | Filed |
External engagement & recognition
Organisation | Country |
---|---|
Academia Sinica | TAIWAN |
Adelaide Pathology Partners | AUSTRALIA |
Agency for Science, Technology and Research (A*STAR) | SINGAPORE |
Australian National Fabrication Facility Limited | AUSTRALIA |
Australian Nuclear Science and Technology Organisation | AUSTRALIA |
Australian Synchrotron | AUSTRALIA |
Austrian Institute of Technology | SWITZERLAND |
Babol Noshirvani University of Technology | IRAN |
Bionomics Ltd. | AUSTRALIA |
Boutiq Science Ltd | NEW ZEALAND |
Carina Biotech | AUSTRALIA |
Ceramisphere | AUSTRALIA |
CeramiSphere Pty Ltd | AUSTRALIA |
Children's Cancer Institute Australia | AUSTRALIA |
Chinese Academy of Sciences | CHINA |
Chinese University of Hong Kong | HONG KONG |
CSIRO Australia (Commonwealth Scientific Industrial Research Organisation) | AUSTRALIA |
Curtin University | AUSTRALIA |
Dana-Farber Cancer Institute | UNITED STATES |
Deakin University | AUSTRALIA |
Ferronova | AUSTRALIA |
Ferronova Pty Ltd | AUSTRALIA |
Ferronova Pty Ltd Salisbury South | AUSTRALIA |
First Affiliated Hospital of Zhengzhou University | CHINA |
Flinders University | AUSTRALIA |
Forschungszentrum Julich | GERMANY |
Fudan University | CHINA |
Guilin University of Electronic Technology | CHINA |
Hanoi University of Science and Technology | VIET NAM |
Hanson Institute | AUSTRALIA |
Harbin Institute of Technology | CHINA |
Harvard University | UNITED STATES |
High Performance Computing | SINGAPORE |
Imperial College of Science, Technology and Medicine | UNITED KINGDOM |
Institute of Medical and Veterinary Science | AUSTRALIA |
Laboratoire de Biologie Moleculaire et de Genie genetique | BELGIUM |
Leiden University | NETHERLANDS |
Leland Stanford Junior University (Stanford) | UNITED STATES |
Magnetic Insight | UNITED STATES |
Marinova Pty Ltd | AUSTRALIA |
McGill University | CANADA |
Memorial Sloan Kettering Cancer Centre | UNITED STATES |
Minomic Pty Ltd | AUSTRALIA |
Monash IVF Group | AUSTRALIA |
Monash University | AUSTRALIA |
Montreal Heart Institute | CANADA |
Murdoch University | AUSTRALIA |
Nanjing Agricultural University | CHINA |
Nanjing Forestry University | CHINA |
Nanjing Medical University | CHINA |
Nanjing University | CHINA |
Nanyang Technological University | SINGAPORE |
National Center for Technological Progress | VIET NAM |
Netherlands Cancer Institute | NETHERLANDS |
Peter Grunberg Institute (PGI) | GERMANY |
Peter MacCallum Cancer Centre | AUSTRALIA |
Prince of Wales Hospital | AUSTRALIA |
Private Individual | AUSTRALIA |
Purdue University | UNITED STATES |
Queen Elizabeth Hospital | AUSTRALIA |
Queensland University of Technology | AUSTRALIA |
Repromed | AUSTRALIA |
RMIT University | AUSTRALIA |
Royal Adelaide Hospital | AUSTRALIA |
SA Pathology | AUSTRALIA |
SA Water Corporation | AUSTRALIA |
Sechenov First Moscow State Medical University | RUSSIAN FEDERATION |
Shanghai Jiao Tong University | CHINA |
Shimadzu Biomedical Research Laboratory | CHINA |
Soochow Uiniversity | CHINA |
Southeast University | CHINA |
Southern Medical University | CHINA |
St George Hospital | AUSTRALIA |
Stanford University | UNITED STATES |
Sung Kyun Kwan University | KOREA, REPUBLIC OF (SOUTH) |
Swiss Federal Institute of Technology Zurich (ETH) | SWITZERLAND |
Tabasco Advance Science and Technology Research Center | MEXICO |
Tabriz University of Medical Sciences | IRAN |
Tabsco Center for Applied Science and Technology Research | MEXICO |
Technical University Munich | GERMANY |
The University of Tennessee Health Science Center | UNITED STATES |
Universita degli Studi di Pavia (AKA Institute for Advanced Study of Pavia) | ITALY |
University College Dublin | IRELAND |
University of Adelaide | AUSTRALIA |
University of California | UNITED STATES |
University of Canterbury | NEW ZEALAND |
University of Edinburgh | UNITED KINGDOM |
University of Helsinki | FINLAND |
University of Melbourne | AUSTRALIA |
University of Montreal | CANADA |
University of New South Wales | AUSTRALIA |
University of Nottingham | UNITED KINGDOM |
University Of Oklahoma Norman | UNITED STATES |
University of Oulu | FINLAND |
University of Pavia | ITALY |
University of Queensland | AUSTRALIA |
University of South Australia | AUSTRALIA |
University of Sydney | AUSTRALIA |
University of Technology Sydney | AUSTRALIA |
University of Tokyo | JAPAN |
University of Toronto | CANADA |
University of Warwick | UNITED KINGDOM |
University of Wisconsin-Madison | UNITED STATES |
UNSW Sydney | AUSTRALIA |
WARTN | AUSTRALIA |
Western Sydney University | AUSTRALIA |
Women's and Children's Hospital | AUSTRALIA |
Yangzhou University | CHINA |
External engagement & recognition
Engagement/recognition | Year |
---|---|
Editorial Board MemberScientific Reports (Nature Publishing Group) |
2018 |
Panel member, Early Career Fellowship SchemeNational Health and Medical Research Council (NHMRC) |
2015 |
Career Development FellowshipNational Health and Medical Research Council (NHMRC) |
2014 |
Expert panel member, Program Grant SchemeNational Health and Medical Research Council (NHMRC) |
2014 |
Best paper award, Wafer-Scale Fabrication of Ultra-Thin Silicon Nanowire Devices13th IEEE International Conference on Nanotechnology, Beijing |
2013 |
Panel member, Project Grants Peer Review ProcessNational Health and Medical Research Council (NHMRC) |
2012 |
Career Development FellowshipNational Health and Medical Research Council (NHMRC) |
2010 |
Prof Thierry is the head of the BioEngineering group at the UniSA Future Industries Institute. The group is hosted in the state-of-the-art MM building and is a dynamic multidisciplinary team with expertise in physics, nanoscience, pharmaceutical science, molecular biology and biomedical engineering. The group has a strong network of collaborators including with prestigious international research institutions such as the University of Stanford, the University of Tokyo, the Beijing CAS Centre for Nanoscience and Technology, the Forschungszentrum Juelich, Harvard University Dana-Farber Cancer Institute and McGill University. Several current and past members of the group have received prestigious awards, inluding a 2019 Tall Poppy award (Dr. Marnie Winter), a Women in Technology Rising Star Award (Dr Michelle Liu) and a finalist award in the 2018 Prime Minister’s Prizes for Science (Dr Aidan Cousins).
Prof Thierry served as the Program Coordinator of the UniSA NanoBioMaterials Honours degree from 2010 to 2017. He is also teaching in various undergraduate and postgraduate programs, including Monash University and SouthEast University (Nanjing, China).
Teaching & student supervision
Supervisions from 2010 shown
Thesis title | Student status |
---|---|
110450 - Development of a theranostic agent for image-guided and radiosensitisation of pancreatic cancer | Current |
111188 - Development of brain tumour-targeting ICG nanoformulations for fluorescence-guided neurosurgery | Current |
Bioengineering for preterm birth: Developing improved vaginal drug delivery formulations and in vitro models | Current |
Developing a Nano-Transistor Biosensor Platform for Point-of-care Diagnostic of Adverse Birth Outcomes | Current |
Development of a wearable electrocardiogram nanosensor for screening hypertensive pregnancy complications | Current |
Molecular mechanisms of M cell signalling in the small intestine | Current |
Next generation bioengineered in vitro tumour models | Current |
Non-invasive prenatal testing using extracellular vesicle derived fetal DNA | Current |
Solid state biosensors with adjustable dynamic range towards Point of Care diagnostics prognostics of infectious disease | Current |
Towards Precision Cancer Radiotherapy through Patient-Derived Tumour on-Chips Reconstructing the Tumour Microenvironment | Current |
A nanomedicine approach for immune checkpoint inhibition: towards better and safer cancer immunotherapy | Completed |
Amplification of surface plasmon resonance biomolecular binding events: towards improved biosensing based cancer prognostics | Completed |
Beyond the gastrointestinal cell layer: replication of the complex oral absorption barrier through enhanced in vitro models for nanoparticulate oral protein delivery | Completed |
Bioengineered vascularized microfluidic model: towards improved cancer therapy risk reduction and in vitro evaluation of the metastatic process | Completed |
Cation exchange reaction in colloidal nanocrystals: a versatile approach towards improved cancer imaging and radiotherapy | Completed |
Detection and characterisation of rare disseminated cancer cells; towards improved patient prognostication | Completed |
Development of a solid-state biodiagnostic platform based on indium oxide nanoribbon field effect transistors | Completed |
Development of imaging methods/models to study oral vaccination and/or delivery of biologics | Completed |
Enrichment and proteomic analysis of placenta-specific extracellular vesicles towards non-invasive diagnosis of preeclampsia | Completed |
Formation and characterisation of fucoidan-based polyelectrolyte multilayers for applications in biomaterials | Completed |
High density lipoprotein: a natural multi-functional nanomedicine for targeted delivery of radiosensitisers to the tumour microenvironment | Completed |
Improving nitric oxide delivery to staphylococcus aureus biofilms | Completed |
Isolation and analysis of circulating fetal cells: towards improved non-invasive prenatal diagnosis of genetic disorders | Completed |
Long-range surface plasmon resonance biosensing structures for mammalian-cell studies | Completed |
Microfluidic intestine-on-a-chip in vitro models for improved mechanistic understanding of intestinal drug and particulate carrier uptake | Completed |
Microfluidic intestine-on-a-chip in vitro models for improved understanding of intestinal particulate carrier absorption and interaction with mucus | Completed |
Microfluidic manufacturing of chimeric antigen receptor t-cells | Completed |
Novel fabrication and operation of integrated silicon nanowire field effect biosensors for reliable detection of cancer prognostic biomarkers | Completed |
Novel handheld magnetometer probe for improved intraoperative detection of sentinel lymph nodes in cancer patients | Completed |
Radiosensitization of cell sub-populations by gold nanoparticles: cross-correlative microscopy for elucidating fundamental mechanisms | Completed |
Single cell analysis of gold and gold-core/silica-shell nanoparticles for radiosensitisation | Completed |
Transport of immuno-targeted nanoparticles in 3D tumor spheroids and in vivo models | Completed |